SLC25A32 and breast cancer: GSEA revealed that SLC25A32 was enriched in PI3KAKTMTORSIGNALING _PATHWAY and EXTRACELcLULAR_ MATRIX_ ORGANIZATION pathways in breast cancer (Figures 8(a) and 8(b)).